azelnidipine

⇄

T cell immunoreceptor with Ig and ITIM domains ; Homo sapiens







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34068552 Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPĪ± and TIGIT/PVR Pathways for Cancer Immuno-Therapy. 2021 May 10 2